Beth Brooke
Brooke is the former global vice chair of public policy at Ernst & Young. In the Clinton Administration, she worked in the U.S. Department of the Treasury and was responsible for tax-policy matters related to healthcare reform, insurance, and managed care. She currently serves on the board of eHealth Inc. and the United States Olympic and Paralympic Committee. She has been named by Forbes to its list of 100 Most Powerful Women eleven times, and is in the OutStanding LGBT Hall of Fame.
- March 2021
Added to: Beta Bionics - Boston, MA
Beta Bionics is a medical technology company developing the iLet, the world's first fully automated bionic pancreas system. Beta Bionics is pursuing regulatory clearance of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates.